How do I know if the surgical team and the hospital are qualified to perform treatment for pseudomyxoma with HIPEC?

9 de December de 2020

In Brazil, almost all surgeons involved in the treatment of pseudomyxoma are trained oncological surgeons. However, training in oncological surgery alone is not sufficient in terms of professional preparation. The training to perform cytoreduction with HIPEC is lengthy, ideally one to two years, and is usually conducted outside Brazil.

The main questions to ask the surgical team are:

– Where did they receive training to perform HIPEC?

– How many HIPEC procedures have they performed to date? How many of these were for pseudomyxoma?

– How many HIPEC procedures, especially for pseudomyxoma, does the team perform each year?

The so-called “learning curve” for treating pseudomyxoma is long. According to the largest study related to the subject published to date (https://pubmed.ncbi.nlm.nih.gov/32833761/), it is recommended that the lead surgeon have performed at least 100 procedures and treat at least 30 patients per year with this technique.

Studies show that patients treated in centers with surgeons who have less experience than this, and who perform the surgery less frequently, can expect inferior results, with a higher risk of mortality, surgical complications, and a reduced chance of curing the disease.

DR. ANDREA PETRUZZIELLO - Médico Cirurgião Oncológico Especialista em Pseudomixoma peritonetal
Dr. Andrea Petruzziello
Dr. Andrea Petruzziello é portador dos registros CRM-SP 187783 e CRM-PR 26107, é um Cirurgião Oncológico especializado em cirurgia de peritônio, fígado, vias biliares e pâncreas. Ele atua como Coordenador do Grupo de Oncologia Peritoneal e possui formação avançada em sua área, tendo se especializado pelo Instituto do Câncer de Montpellier e pelas Universidades Paris-SUD, Paris-Diderot e Lyon-1, na França.

Leave a Reply

Your email address will not be published. Required fields are marked *

Agendar consulta
desenvolvido com coração por evonline Pseudomixoma Peritoneal © 2026